// App-Quantinova.ai

TCT-36 : Complete Revascularization Versus Culprit Lesion–Only PCI in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease: A Subgroup Analysis of the COMPLETE Trial

Researchers

Presenter

  • Zardasht Oqab

Principal Investigators

  • Vijay Kunadian

  • David Wood

  • Sunil Rao

  • Roxana Mehran

  • Natalia Pinilla

  • Robert Storey

  • Robert Boone

  • Matthew Sibbald

  • Nicholas Valettas

  • Raul Moreno

  • Philippe Gabriel Steg

  • John Cairns

  • Shamir Mehta

Medical Centers

  • University Hospital La Paz, Madrid, Spain

  • University of Sheffield, Sheffield, United Kingdom

  • St Paul’s Hospital/University of British Columbia, Vancouver, British Columbia, Canada

  • NYU Langone Health, New York, New York, USA

  • Hopital Bichat, Paris, France

  • University of British Columbia Centre for Cardiovascular Innovation, Vancouver, British Columbia, Canada

  • Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada

  • McMaster University, Oakville, Ontario, Canada

  • University of Alberta, Edmonton, Alberta, Canada

  • Hamilton Health Sciences, Hamilton, Ontario, Canada

  • McMaster University, Hamilton, Ontario, Canada

  • Freeman Hospital, Newcastle upon Tyne, United Kingdom

  • Mount Sinai Heart Health System, New York, New York, USA

Locations

  • Spain

  • United Kingdom

  • Canada

  • United States

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Cardiovascular (CVS)

Disease

  • Multi-vessel disease

  • Myocardial infarction

  • Diabetes

  • Coronary Artery Disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved